Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
7 citing papers in PubMed, 6 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors at 4 institutions in 4 countries.
Leticia Pérez-SisquésCentre for Craniofacial and Regenerative Biology, Guy's Hospital, King's College London, London SE1 9RT, United Kingdom.ORCID 0000-0002-9682-9811
Shail U BhattCentre for Craniofacial and Regenerative Biology, Guy's Hospital, King's College London, London SE1 9RT, United Kingdom.ORCID 0000-0002-4399-133X
Rugile MatuleviciuteMRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE1 1UL, United Kingdom.
Talia E GileadiCentre for Craniofacial and Regenerative Biology, Guy's Hospital, King's College London, London SE1 9RT, United Kingdom.ORCID 0000-0002-8155-6822
Eniko KramarDepartment of Neurobiology and Behavior, School of Biological Sciences, University of California Irvine, Irvine, California, California 92697.
Andrew GrahamCentre for Craniofacial and Regenerative Biology, Guy's Hospital, King's College London, London SE1 9RT, United Kingdom.ORCID 0000-0002-7646-8705
Franklin G GarciaDepartment of Neurobiology and Behavior, School of Biological Sciences, University of California Irvine, Irvine, California, California 92697.ORCID 0000-0002-3949-9633
Ashley KeiserDepartment of Neurobiology and Behavior, School of Biological Sciences, University of California Irvine, Irvine, California, California 92697.
Dina P MatheosDepartment of Neurobiology and Behavior, School of Biological Sciences, University of California Irvine, Irvine, California, California 92697.ORCID 0000-0002-0324-8365
James A CainCentre for Craniofacial and Regenerative Biology, Guy's Hospital, King's College London, London SE1 9RT, United Kingdom.ORCID 0000-0001-8141-0666
Alan M PittmanSt. George's University of London, London SW17 0RE, United Kingdom.
Laura C AndreaeMRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE1 1UL, United Kingdom.ORCID 0000-0003-3686-3927
Cathy FernandesMRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE1 1UL, United Kingdom.ORCID 0000-0001-7318-3352
Marcelo A WoodDepartment of Neurobiology and Behavior, School of Biological Sciences, University of California Irvine, Irvine, California, California 92697.
K Peter GieseDepartment of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Maurice Wohl Clinical Neuroscience Institute, London SE5 9RT, United Kingdom.ORCID 0000-0003-4503-7344
M Albert BassonCentre for Craniofacial and Regenerative Biology, Guy's Hospital, King's College London, London SE1 9RT, United Kingdom m.a.basson@exeter.ac.uk.ORCID 0000-0001-9834-7528
Guy's Hospital · GBUniversity of California, Irvine · USKing's College London · GBSt George's, University of London · GB
Funding
Epigenetic suppression of histone methylation reverses age and AD-related cognitive declineRF1AG057558 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI WOOD, MARCELO ANDRES · 2018 to 2018
$3.8M
Delineating how epigenetic regulation of ACVR1C contributes to age and AD-related memory impairments in females and malesK99AG078501 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI KEISER, ASHLEY A · 2022 to 2023
$219k
Investigating the role of Crest, an epigenetic mechanism coordinator, in the adult and aging/AD brainF32AG077872 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI GARCIA, FRANKLIN · 2022 to 2022
$72k
Medical Research Council MR/V013173/1NIA NIH HHS F32 AG077872NIA NIH HHS K99 AG078501NIA NIH HHS RF1 AG057558Wellcome Trust
6 · The paper itself
Abstract
The histone lysine demethylase KDM5B is implicated in recessive intellectual disability disorders, and heterozygous, protein-truncating variants in
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
The Intellectual Disability Risk Gene · full record | OpenQuestion